Boosting of CAR-T cells with rhabdovirus is limited by type I interferon and rapid contraction
Rebecca Burchett, Claire G. Morris, Mira Ishak, Derek T. Cummings, Christopher L. Baker, Ricardo M. Marius, Natasha Kazdhan, Christopher M. Silvestri, John C. Bell, Brian Dennis Lichty, Scott R. Walsh, Yonghong Wan, Joanne A. Hammill, Jonathan L. Bramson
This study shows that boosting CAR-T cells with a VSV vaccine encoding the CAR-target leads to robust expansion but rapid contraction, while TCR-mediated boosting improves persistence and tumor eradication.
bioRxiv · Nov 29, 2024 · PreprintImmunology